Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study-Reference-Cited by-同舟云学术

Neoadjuvant PD-1 blockade with sintilimab in mismatch-repair deficient, locally advanced rectal cancer: an open-label, single-centre phase 2 study

Published:2023-05 Issue:5 Volume:8 Page:422-431
ISSN:2468-1253
Container-title:The Lancet Gastroenterology & Hepatology
language:en
Short-container-title:The Lancet Gastroenterology & Hepatology

Author:

Chen Gong,Jin Ying,Guan Wen-Long,Zhang Rong-Xin,Xiao Wei-Wei,Cai Pei-Qiang,Liu Min,Lin Jun-Zhong,Wang Fu-Long,Li Cong,Quan Ting-Ting,Xi Shao-Yan,Zhang Hui-Zhong,Pan Zhi-Zhong,Wang Feng,Xu Rui-Hua

Funder

National Natural Science Foundation of China

Chinese Academy of Meteorological Sciences

Guangzhou Science and Technology Program key projects

Guangzhou Science Technology and Innovation Commission

CAMS Innovation Fund for Medical Sciences

Innovent Biologics

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference37 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. A global assessment of recent trends in gastrointestinal cancer and lifestyle-associated risk factors;Lu;Cancer Commun,2021

3. Preoperative versus postoperative chemoradiotherapy for rectal cancer;Sauer;N Engl J Med,2004

4. Preoperative versus postoperative chemoradiotherapy for locally advanced rectal cancer: results of the German CAO/ARO/AIO-94 randomized phase III trial after a median follow-up of 11 years;Sauer;J Clin Oncol,2012

5. Chemoradiotherapy with capecitabine versus fluorouracil for locally advanced rectal cancer: a randomised, multicentre, non-inferiority, phase 3 trial;Hofheinz;Lancet Oncol,2012

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of neoadjuvant chemoradiotherapy with or without PD-1 antibody sintilimab in pMMR locally advanced rectal cancer: A randomized clinical trial;Cancer Cell;2024-09

2. Oncological characteristics, treatments and prognostic outcomes in MMR-deficient colorectal cancer;Biomarker Research;2024-08-26

3. Neoadjuvant immunotherapy plus radiation effective in advanced MSI-H rectal cancer;Medicom Conference Report ESMO GI 2024;2024-08-21

4. Recent developments in immunotherapy for gastrointestinal tract cancers;Journal of Hematology & Oncology;2024-08-09

5. Programmed cell death 1 inhibitor sintilimab plus concurrent chemoradiotherapy for locally advanced pancreatic adenocarcinoma;World Journal of Clinical Oncology;2024-07-24